Key facts
- This page summarizes Todd M. Duchene's Form 4 filing for Core Scientific, Inc./tx (CORZ).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Sep 2026, 16:08.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Gift
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
Footnote F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $19.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Footnote F3
Reflects the transfer of 700,000 shares that the Reporting Person held directly to a grantor retained annuity trust of which the Reporting Person is the sole trustee on September 10, 2026, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.
Footnote F4
Represents shares held by a grantor retained annuity trust of which the Reporting Person is the sole trustee.
Footnote F5
Reflects a charitable donation.
Footnote F6
Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
SEC remarks
Chief Legal and Administrative Officer